Literature DB >> 29724918

Management appropriateness and outcomes of patients with acute pulmonary embolism.

David Jiménez1,2, Behnood Bikdeli3,4,2, Deisy Barrios1, Raquel Morillo1, Rosa Nieto1, Ina Guerassimova1, Alfonso Muriel5, Luis Jara-Palomares6, Lisa Moores7, Victor Tapson8, Roger D Yusen9, Manuel Monreal10,11.   

Abstract

The impact of adherence to published guidelines on the outcomes of patients with acute pulmonary embolism (PE) has not been well defined by previous studies.In this prospective cohort study of patients admitted to a respiratory department (n=2096), we evaluated whether patients with PE had better outcomes if they were acutely managed according to international guidelines. Outcomes consisted of all-cause mortality, PE-related mortality, recurrent venous thromboembolism (VTE) and major bleeding events during the first month of follow-up after diagnosis.Overall, 408 patients (19% (95% CI 18-21%)) did not receive guideline-adherent PE management. Patients receiving non-adherent management were significantly more likely to experience all-cause mortality (adjusted odds ratio (OR) 2.39 (95% CI 1.57-3.61) or PE-related mortality (adjusted OR 5.02 (95% CI 2.42-10.42); p<0.001) during follow-up. Non-adherent management was also a significant independent predictor of recurrent VTE (OR 2.19 (95% CI 1.11-4.32); p=0.03) and major bleeding (OR 2.65 (95% CI 1.66-4.24); p<0.001). An external validation cohort of 34 380 patients with PE from the RIETE registry confirmed these findings.PE management that does not adhere to guidelines for indications related to anticoagulation, thrombolytics and inferior vena cava filters is associated with worse patient outcomes.
Copyright ©ERS 2018.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29724918     DOI: 10.1183/13993003.00445-2018

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  5 in total

1.  Key topics in pulmonary vascular diseases (assembly 13) from the European Respiratory Society 2018 Parisian Congress.

Authors:  Sheila Ramjug; Anton Vonk Noordegraaf; Marion Delcroix
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

2.  LMWHs dosage and outcomes in acute pulmonary embolism with renal insufficiency, an analysis from a large real-world study.

Authors:  Dingyi Wang; Guohui Fan; Jieping Lei; Yuanhua Yang; Xiaomao Xu; Yingqun Ji; Qun Yi; Hong Chen; Xiaoyun Hu; Zhihong Liu; Yimin Mao; Jie Zhang; Juhong Shi; Zhu Zhang; Sinan Wu; Xincao Tao; Wanmu Xie; Jun Wan; Yunxia Zhang; Shuai Zhang; Kaiyuan Zhen; Zhonghe Zhang; Baomin Fang; Chen Wang; Zhenguo Zhai
Journal:  Thromb J       Date:  2022-05-05

3.  The dating of thrombus organization in cases of pulmonary embolism: an autopsy study.

Authors:  Gelsomina Mansueto; Dario Costa; Emanuele Capasso; Federica Varavallo; Giuseppina Brunitto; Rosanna Caserta; Salvatore Esposito; Massimo Niola; Celestino Sardu; Raffaele Marfella; Claudio Napoli; Mariano Paternoster
Journal:  BMC Cardiovasc Disord       Date:  2019-11-08       Impact factor: 2.298

4.  Secondary prevention of venous thromboembolism: Predictors and outcomes of guideline adherence in a long-term prospective cohort study.

Authors:  Tamara Mertins; Henning Nilius; Robin Boss; Matthias Knuchel; Andri Signorell; Carola A Huber; Eva Blozik; Johanna Anna Kremer Hovinga; Lucas M Bachmann; Michael Nagler
Journal:  Front Cardiovasc Med       Date:  2022-08-03

5.  Anticoagulant for treatment and prophylaxis of venous thromboembolism patients with renal dysfunction: A systematic review and network meta-analysis.

Authors:  Guohui Fan; Dingyi Wang; Meng Zhang; Xufei Luo; Zhenguo Zhai; Sinan Wu
Journal:  Front Med (Lausanne)       Date:  2022-09-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.